First Time Loading...
K

Knight Therapeutics Inc
TSX:GUD

Watchlist Manager
Knight Therapeutics Inc
TSX:GUD
Watchlist
Price: 5.77 CAD Market Closed
Updated: May 2, 2024

Knight Therapeutics Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Knight Therapeutics Inc
Revenue Peer Comparison

Comparables:
BHC
WEED
CRON
C
CURA
T
TER

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
K
Knight Therapeutics Inc
TSX:GUD
Revenue
CA$328.2m
CAGR 3-Years
18%
CAGR 5-Years
92%
CAGR 10-Years
N/A
Bausch Health Companies Inc
TSX:BHC
Revenue
$8.8B
CAGR 3-Years
3%
CAGR 5-Years
1%
CAGR 10-Years
4%
Canopy Growth Corp
TSX:WEED
Revenue
CA$298.1m
CAGR 3-Years
-16%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Cronos Group Inc
TSX:CRON
Revenue
$87.2m
CAGR 3-Years
23%
CAGR 5-Years
48%
CAGR 10-Years
N/A
C
Curaleaf Holdings Inc
CNSX:CURA
Revenue
$2.3B
CAGR 3-Years
71%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Terrascend Corp
CNSX:TER
Revenue
$247.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Knight Therapeutics Inc's Revenue?
Revenue
328.2m CAD

Based on the financial report for Dec 31, 2023, Knight Therapeutics Inc's Revenue amounts to 328.2m CAD.

What is Knight Therapeutics Inc's Revenue growth rate?
Revenue CAGR 5Y
92%

Over the last year, the Revenue growth was 12%. The average annual Revenue growth rates for Knight Therapeutics Inc have been 18% over the past three years , 92% over the past five years .